CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
0.4264
+0.0060 (1.42%)
May 22, 2026, 4:00 PM EDT - Market closed
CollPlant Biotechnologies Revenue
In the year 2025, CollPlant Biotechnologies had annual revenue of $2.37M with 360.39% growth. CollPlant Biotechnologies had revenue of $60.00K in the quarter ending December 31, 2025, a decrease of -63.41%.
Revenue (ttm)
$2.37M
Revenue Growth
+360.39%
P/S Ratio
2.55
Revenue / Employee
$60,795
Employees
39
Market Cap
6.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.37M | 1.86M | 360.39% |
| Dec 31, 2024 | 515.00K | -10.44M | -95.30% |
| Dec 31, 2023 | 10.96M | 10.66M | 3,565.22% |
| Dec 31, 2022 | 299.00K | -15.34M | -98.09% |
| Dec 31, 2021 | 15.64M | 9.50M | 154.86% |
| Dec 31, 2020 | 6.14M | 3.82M | 164.75% |
| Dec 31, 2019 | 2.32M | -2.70M | -53.77% |
| Dec 31, 2018 | 5.01M | 4.55M | 982.94% |
| Dec 31, 2017 | 463.00K | 387.12K | 510.15% |
| Dec 31, 2016 | 75.88K | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 3.19M |
| BioAtla | 2.00M |
| XTL Biopharmaceuticals | 968.00K |
| GeoVax Labs | 852.28K |
| Silo Pharma | 72.10K |
| Alaunos Therapeutics | 3.00K |
| Virax Biolabs Group | 2.99K |
CLGN News
- 5 weeks ago - CollPlant Biotechnologies Registration statement: Registration filing - Filings
- 5 weeks ago - CollPlant Issues Letter to Shareholders - PRNewsWire
- 7 weeks ago - CollPlant files to sell 3.3M ordinary shares for holders - TheFly
- 7 weeks ago - CollPlant Biotechnologies Registration statement: Registration filing - Filings
- 2 months ago - CollPlant Biotechnologies Earnings release: Q4 2025 - Filings
- 2 months ago - CollPlant Biotechnologies Annual report: Q4 2025 - Filings
- 2 months ago - COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - PRNewsWire
- 2 months ago - CollPlant receives non-compliance letter from Nasdaq - TheFly